nitroglycerin has been researched along with Atheroma in 4 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coronary vasodilator function and atherosclerotic plaque progression have both been shown to be associated with adverse cardiovascular events." | 2.87 | Evaluation of human coronary vasodilator function predicts future coronary atheroma progression. ( Baillie, TJ; Beltrame, JF; Delacroix, S; Honda, S; Howell, S; Kim, S; Montarello, N; Nicholls, SJ; Psaltis, PJ; Shishikura, D; Sidharta, SL; Worthley, MI; Worthley, SG, 2018) |
| "Nitroglycerin was administered prior to CT, QCA and FFR acquisition." | 2.84 | Effect of the ratio of coronary arterial lumen volume to left ventricle myocardial mass derived from coronary CT angiography on fractional flow reserve. ( Achenbach, S; Ahmadi, A; Berman, DS; Bezerra, H; Bøtker, HE; De Bruyne, B; Dey, D; Gaur, S; Jensen, JM; Khem, S; Kim, HJ; Ko, B; Leipsic, J; Lesser, J; Narula, J; Nørgaard, BL; St Goar, F; Taylor, CA; Wilk, A; Zarins, CK; Øvrehus, KA, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taylor, CA | 1 |
| Gaur, S | 1 |
| Leipsic, J | 1 |
| Achenbach, S | 1 |
| Berman, DS | 1 |
| Jensen, JM | 1 |
| Dey, D | 1 |
| Bøtker, HE | 1 |
| Kim, HJ | 1 |
| Khem, S | 1 |
| Wilk, A | 1 |
| Zarins, CK | 1 |
| Bezerra, H | 1 |
| Lesser, J | 1 |
| Ko, B | 1 |
| Narula, J | 1 |
| Ahmadi, A | 1 |
| Øvrehus, KA | 1 |
| St Goar, F | 1 |
| De Bruyne, B | 2 |
| Nørgaard, BL | 1 |
| Sidharta, SL | 1 |
| Baillie, TJ | 1 |
| Howell, S | 1 |
| Nicholls, SJ | 1 |
| Montarello, N | 1 |
| Honda, S | 1 |
| Shishikura, D | 1 |
| Delacroix, S | 1 |
| Kim, S | 1 |
| Beltrame, JF | 1 |
| Psaltis, PJ | 1 |
| Worthley, SG | 1 |
| Worthley, MI | 1 |
| Antignani, PL | 1 |
| Benedetti-Valentini, F | 1 |
| Aluigi, L | 1 |
| Baroncelli, TA | 1 |
| Camporese, G | 1 |
| Failla, G | 1 |
| Martinelli, O | 1 |
| Palasciano, GC | 1 |
| Pulli, R | 1 |
| Rispoli, P | 1 |
| Amato, A | 1 |
| Amitrano, M | 1 |
| Dorigo, W | 1 |
| Gossetti, B | 1 |
| Irace, L | 1 |
| Laurito, A | 1 |
| Magnoni, F | 1 |
| Minucci, S | 1 |
| Pedrini, L | 1 |
| Righi, D | 1 |
| Verlato, F | 1 |
| Brugaletta, S | 1 |
| Heo, JH | 1 |
| Garcia-Garcia, HM | 1 |
| Farooq, V | 1 |
| van Geuns, RJ | 1 |
| Dudek, D | 1 |
| Smits, PC | 1 |
| Koolen, J | 1 |
| McClean, D | 1 |
| Dorange, C | 1 |
| Veldhof, S | 1 |
| Rapoza, R | 1 |
| Onuma, Y | 1 |
| Bruining, N | 1 |
| Ormiston, JA | 1 |
| Serruys, PW | 1 |
1 review available for nitroglycerin and Atheroma
| Article | Year |
|---|---|
Diagnosis of vascular diseases. Ultrasound investigations--guidelines.
Topics: Ankle Brachial Index; Blood Circulation; Blood Flow Velocity; Blood Gas Monitoring, Transcutaneous; | 2012 |
3 trials available for nitroglycerin and Atheroma
| Article | Year |
|---|---|
Effect of the ratio of coronary arterial lumen volume to left ventricle myocardial mass derived from coronary CT angiography on fractional flow reserve.
Topics: Aged; Area Under Curve; Cardiac Catheterization; Chi-Square Distribution; Computed Tomography Angiog | 2017 |
Evaluation of human coronary vasodilator function predicts future coronary atheroma progression.
Topics: Aged; Albuterol; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progressio | 2018 |
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therap
Topics: Absorbable Implants; Acetylcholine; Aged; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascul | 2012 |